Barbara Schreier

Dr. Barbara Schreier

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Hypertension
Verified
Journal Article
Closed access
PDF file
BSBarbara Schreier
Barbara Schreier
SRSindy Rabe
Sindy Rabe
BSBettina Schneider
Bettina Schneider
MBMaria Bretschneider
Maria Bretschneider
SRSebastian Rupp
Sebastian Rupp
MGMichael Gekle
Michael Gekle
The epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, contributes to parainflammatory dysregulation, possibly causing cardiovascular dysfunction and remodeling. The physiological role of cardiovascular EGFR is not completely understood. To investigate the physiological importance of EGFR in vascular smooth muscle cells and cardiomyocytes, we generated a mouse model with targeted deletion of the EGFR using the SM22 (smooth muscle-specific protein 22) promoter. While the reproduction of knockout animals was not impaired, life span was significantly reduced. Systolic blood pressure was not different between the 2 genotypes—neither in tail cuff nor in intravascular measurements—whereas total peripheral vascular resistance, diastolic blood pressure, and mean blood pressure were reduced. Loss of vascular smooth muscle cell-EGFR results in a dilated vascular phenotype with minor signs of fibrosis and inflammation. Echocardiography, necropsy, and histology revealed a dramatic eccentric cardiac hypertrophy in knockout mice (2.5-fold increase in heart weight), with increased stroke volume and cardiac output as well as left ventricular wall thickness and lumen. Cardiac hypertrophy is accompanied by an increase in cardiomyocyte volume, a strong tendency to cardiac fibrosis and inflammation, as well as enhanced NADPH-oxidase 4 and hypertrophy marker expression. Thus, in cardiomyocytes, EGFR prevents excessive hypertrophic growth through its impact on reactive oxygen species balance, whereas in vascular smooth muscle cells EGFR contributes to the appropriate vascular wall architecture and vessel reactivity, thereby supporting a physiological vascular tone.

24 February 2011 in Hypertension Research
Verified
Journal Article
Open access
PDF file
BSBarbara Schreier
Barbara Schreier
SRSindy Rabe
Sindy Rabe
BSBettina Schneider
Bettina Schneider
SRStefanie Ruhs
Stefanie Ruhs
CGClaudia Grossmann
Claudia Grossmann
MGMichael Gekle
Michael Gekle
We examined the contribution of transforming growth factor (TGF)-β-T-cell signaling to aldosterone (aldo)/salt-induced fibrosis in the kidneys and the hearts of FVB/N wild-type (WT) or transgenic (Tg) mice expressing a dominant-negative TGF-β type II receptor in T cells (hCD2-ΔkTβRII). Animals received aldo through osmotic minipumps and had access to either 1% NaCl (aldo/NaCl group) or tap water (vehicle group) for 4 weeks. Systolic blood pressure was measured during this period via a tail cuff. The animals were then killed, and urine, blood, kidneys and hearts were collected. Systolic blood pressure did not differ between the groups. Aldo/NaCl enhanced renal, cardiac and left ventricular weight in WT animals slightly, but only renal weight was increased in Tg animals. Urinary protein excretion was enhanced in Tg animals (fourfold) and increased further in WT (twofold) and Tg (1.8-fold) mice on aldo/NaCl treatment. Aldo/NaCl increased interstitial fibrosis in the kidneys (1.5-fold) and the hearts of WT (2.5-fold) animals. Under control conditions, Tg mouse cardiac (3.2-fold) and renal (1.7-fold) tissues were slightly more fibrotic compared with WT, and this condition was not further aggravated by aldo/NaCl. Aldo/NaCl-induced mRNA expression of renal fibronectin (10.7-fold in WT) but not of renal collagen mRNA expression (WT: Col1a1 7.7-fold; Col3a1, 3.1-fold; and Col4a1 3.3-fold) was abrogated in Tg animals. In hearts, aldo/NaCl-induced plasminogen activator inhibitor-1 mRNA (twofold) expression depended on TGF-β-T-cell signaling. Our results indicate that (i) aldo/NaCl can induce renal and cardiac damage in the absence of blood pressure changes, (ii) the elimination TGF-β-T-cell cross-talk leads to renal and cardiac fibrosis but does not exacerbate aldo/NaCl-induced damage and (iii) the pathological aldo/NaCl effect is modified, in part, by TGF-β-T-cell cross-talk.

16 July 2019 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
SBStephanie Binas
Stephanie Binas
MKMaria Knyrim
Maria Knyrim
JHJulia Hupfeld
Julia Hupfeld
UKUdo Kloeckner
Udo Kloeckner
SRSindy Rabe
Sindy Rabe
BSBarbara Schreier
Barbara Schreier
MicroRNAs (miRs) contribute to different aspects of cardiovascular pathology, among others cardiac hypertrophy and atrial fibrillation. The aim of our study was to evaluate the impact of miR-221/222 on cardiac electrical remodeling. Cardiac miR expression was analyzed in a mouse model with altered electrocardiography parameters and severe heart hypertrophy. Next generation sequencing revealed 14 differentially expressed miRs in hypertrophic hearts, with miR-221 and -222 being the strongest regulated miR-cluster. This increase was restricted to cardiomyocytes and not observed in cardiac fibroblasts. Additionally, we evaluated the change of miR-221/222 in vivo in two models of pharmacologically induced heart hypertrophy (angiotensin II, isoprenaline), thereby demonstrating a stimulus-induced increase in miR-221/222 in vivo by angiotensin II but not by isoprenaline. Whole transcriptome analysis by RNA-seq and qRT-PCR validation revealed an enriched number of downregulated mRNAs coding for proteins located in the T-tubule, which are also predicted targets for miR-221/222. Among those, mRNAs were the L-type Ca2+ channel subunits as well as potassium channel subunits. We confirmed that both miRs target the 3′-untranslated regions of Cacna1c and Kcnj5. Furthermore, enhanced expression of these miRs reduced L-type Ca2+ channel and Kcnj5 channel abundance and function, which was analyzed by whole-cell patch clamp recordings or Western blot and flux measurements, respectively. miR-221 and -222 contribute to the regulation of L-type Ca2+ channels as well as Kcnj5 channels and, therefore, potentially contribute to disturbed cardiac excitation generation and propagation. Future studies will have to evaluate the pathophysiological and clinical relevance of aberrant miR-221/222 expression for electrical remodeling.

1 July 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
BSBarbara Schreier
Barbara Schreier
GSGerald Schwerdt
Gerald Schwerdt
CHChristian Heise
Christian Heise
DBDaniel Bethmann
Daniel Bethmann
SRSindy Rabe
Sindy Rabe
MGMichael Gekle
Michael Gekle

30 November 2015 in Clinical Science
Verified
Journal Article
Closed access
PDF file
BSBarbara Schreier
Barbara Schreier
MHMirja Hünerberg
Mirja Hünerberg
SRSindy Rabe
Sindy Rabe
SMSigrid Mildenberger
Sigrid Mildenberger
DBDaniel Bethmann
Daniel Bethmann
MGMichael Gekle
Michael Gekle
Epidermal growth factor receptor (EGFR) is activated by its canonical ligands and transactivated by various vasoactive substances, e.g. angiotensin II. Vascular EGFR has been proposed to be involved in vascular tissue homeostasis and remodelling. Thus, most studies focused on its role during long term vascular changes whereas the relevance for acute regulation of vascular function in vivo and ex vivo is insufficiently understood. To investigate the postnatal role of VSMC (vascular smooth muscle cell) EGFR in vivo and ex vivo , we generated a mouse model with cell-specific and inducible deletion of VSMC-EGFR and studied the effect on basal blood pressure, acute pressure response to, amongst others, angiotensin II in vivo as well as ex vivo , cardiovascular tissue homeostasis and vessel morphometry in male mice. In knockout animals, systolic, diastolic and mean blood pressures were reduced compared to wild-type. Furthermore, angiotensin II-induced pressure load was lower in knockout animals, as was angiotensin II-induced force development and ERK1/2-phosphorylation in aortic rings from knockout animals. By contrast, we observed no difference in force development during application of serotonin, KCl, endothelin-1 or endothelin-1-induced pressure load in knockout animals. In addition, NO-mediated vasodilation was not affected. Heart weight increase and upregulation of aortic and cardiac expression of Ccl2 and Serpine1 during the transition from 4 months to 10 months age were prevented by VSMC-EGFR knockout. We conclude that VSMC-EGFR is involved in basal blood pressure homeostasis, acute pressure response to angiotensin II and thereby contributes to maturation-related remodeling.

22 December 2021 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
BSBarbara Schreier
Barbara Schreier
AZAlexander Zipprich
Alexander Zipprich
HUHenriette Uhlenhaut
Henriette Uhlenhaut
MGMichael Gekle
Michael Gekle
Liver diseases are the fourth common death in Europe responsible for about 2 million death per year worldwide. Among the known detrimental causes for liver dysfunction are virus infections, intoxications and obesity. The mineralocorticoid receptor (MR) is a ligand‐dependent transcription factor activated by aldosterone or glucocorticoids but also by pathological milieu factors. Canonical actions of the MR take place in epithelial cells of kidney, colon and sweat glands and contribute to sodium reabsorption, potassium secretion and extracellular volume homeostasis. The non‐canonical functions can be initiated by inflammation or an altered micro‐milieu leading to fibrosis, hypertrophy and remodelling in various tissues. This narrative review summarizes the evidence regarding the role of MR in portal hypertension, non‐alcoholic fatty liver disease, liver fibrosis and cirrhosis, demonstrating that inhibition of the MR in vivo seems to be beneficial for liver function and not just for volume regulation. Unfortunately, the underlying molecular mechanisms are still not completely understood. LINKED ARTICLES: This article is part of a themed issue on Emerging Fields for Therapeutic Targeting of the Aldosterone‐Mineralocorticoid Receptor Signaling Pathway. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.13/issuetoc